DSS 10-Q: Going Concern Warning, Revenue Down 44%, $39.1M Loan in Default
DSS sits 46% above its 52-week low of $0.361.
Summary
DSS reported a 44% drop in quarterly revenue, a $16.3 million nine-month net loss, and explicit going-concern doubt with only $3.3 million of cash against $42.8 million of negative working capital—while a $39.1 million mortgage remains in default.
Key Events · Earnings and Guidance · DSS
-
Going Concern Warning Disclosed
Management states substantial doubt about the ability to continue as a going concern within one year, citing $3.3 million of cash and $42.8 million of negative working capital at September 30, 2026.
-
Revenue Falls 44% in Q3
Third-quarter revenue dropped to $3.604 million from $6.392 million a year earlier; nine-month revenue fell 31% to $11.538 million from $16.630 million as packaging orders missed forecasts and REIT rental income shrank after facility sales.
-
Net Loss Widens to $16.3M
Nine-month net loss was $16.311 million versus $10.087 million in 2025, including $1.44 million of stock-based compensation at Impact BioMedical; operating loss was $13.446 million.
-
$39.1M Mortgage Still in Default
The AMRE LifeCare loan from Pinnacle Bank remains past due after a December 22, 2023 demand for payment; approximately $39.1 million of principal, accrued interest and costs is classified as current.
Analysis · DSS · Manufacturing
The going-concern language is now explicit: substantial doubt about DSS's ability to survive the next twelve months, with $3.3 million of cash against $42.8 million of negative working capital and $3.5 million burned in operations over nine months. Revenue is shrinking fast—third-quarter sales fell 44% to $3.6 million as packaging customers under-ordered and the REIT lost rental income from sold facilities—while the nine-month net loss widened to $16.3 million. On top of that, the $40.3 million Pinnacle Bank mortgage on the medical properties has been in default since a December 2023 demand, with roughly $39.1 million still owed and classified as current. Survival is being funded by related-party convertible notes from Alset (chairman Heng Fai Chan's vehicle), which convert at $0.45-$0.74 per share and came with tens of millions of warrants—paper that would swamp the current 10.0 million shares outstanding if exercised. This is a solvency story, not an earnings story.
How filings like this one have moved
In the 30 days to Nov 12, 2026, 49.5% of the 210 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.54%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, DSS was trading at $0.53 on NYSE in the Manufacturing sector, with a market capitalization of approximately $5.3M. The 52-week trading range was $0.36 to $1.86. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.